Seong Hwi Hong, PHD

Disclosure information not submitted.

Presentation(s):

• PD43-06: EZH2 inhibition as therapeutic strategy to dysregulate LATS1 in RCC

  Sunday, May 15, 2022
  10:20 AM – 10:30 AM